What loan options are available for buying a medical spa?

Buying an existing medical spa involves financing three overlapping asset classes simultaneously: (1) tangible equipment (laser and body-contouring devices, treatment furniture, skincare inventory), (2) leasehold improvements (built-out treatment rooms, plumbing, electrical), and (3) goodwill — the patient base, membership list, brand reputation, medical director relationships, and trained staff that make the practice revenue-generative from day one. Conventional lenders are comfortable with the first two categories; most will not finance goodwill. SBA 7(a) is the acquisition vehicle that solves the goodwill gap: it finances intangibles up to 70–90% of appraised value as part of a total acquisition loan. For a med spa selling for $500,000–$1.5M — a typical range for an established single-location practice — SBA 7(a) gets the deal done at 10–15% buyer equity injection versus 25–40% for conventional acquisition financing.

How patient base, device fleet, and medical-director continuity affect med spa acquisition underwriting

Med spa acquisition underwriters evaluate the target practice on five dimensions: (1) Revenue durability — trailing 12-month revenue normalized for any anomalous periods; membership ARR weighted more heavily than transactional service revenue because it is more predictable. (2) Device fleet condition and age — a practice with $400,000 in 2-year-old FDA-cleared devices is a materially different acquisition than one with $400,000 in 6-year-old platforms nearing obsolescence; buyers should request device serial numbers and 510(k) status and factor replacement costs into the purchase price and financing request. (3) Medical director continuity — if the seller is the medical director, the buyer must secure a new or transitioning medical director before close or within a documented transition window; lenders require a written transition plan or executed replacement agreement. (4) CPOM-compliant buyer entity — the purchasing entity must be organized in compliance with state CPOM law before SBA eligibility determination; organizing a PC or PLLC post-LOI with a physician co-owner is a common path for non-physician buyers. (5) Goodwill valuation — the SBA requires an independent business valuation for acquisition loans over $250,000 where goodwill exceeds 25% of total purchase price; the appraiser values the patient base, memberships, brand, and non-compete agreements.

Med spa acquisition loan mechanics

• SBA 7(a) acquisition loan — up to $5M total; 10-year term; finances equipment + leasehold + goodwill + working capital bridge in one structure; 10–15% equity injection; seller carry (10% of purchase price) accepted in lieu of partial cash injection if seller note is on full standby for 2 years
• Conventional acquisition term loan — 60–84-month terms; finances tangible assets (equipment + leasehold) only; 25–30% down; faster close (2–4 weeks); best for asset-heavy practices where goodwill is a small percentage of total price
• SBA 504 + goodwill bridge — for acquisitions that include real property; 504 finances the building at fixed 20-year CDC rate; 7(a) finances goodwill and equipment; structured as a two-loan stack
• Seller financing — sellers commonly carry 10–20% of purchase price as a subordinated note; SBA allows seller carry if the note is on full standby for the first 2 years of the SBA loan
• Earnout provisions — for practices where revenue durability is uncertain, buyers and sellers negotiate earnouts tied to 12–24-month post-close revenue; lenders model the earnout as contingent consideration and exclude it from DSCR calculation

SBA program fit for med spa acquisitions

The SBA 7(a) program is the dominant financing vehicle for med spa acquisitions because it finances goodwill — the single largest value component in most established practices. Under 13 CFR Part 121, NAICS 812199 entities qualify at average annual receipts under $9.0M. SBA requires an independent business valuation when goodwill exceeds 25% of total transaction value and the loan amount exceeds $250,000. The SBA's goodwill-inclusion policy means that a $1M acquisition with $600,000 in goodwill can close at $100,000–$150,000 buyer equity — versus $250,000–$400,000 for a conventional lender or a bank that refuses to finance intangibles.

Common qualification thresholds for med spa acquisition loans

• SBA 7(a) acquisition: buyer 650+ FICO; target practice DSCR 1.25x on normalized trailing 12-month earnings; 10–15% equity injection; independent business valuation if goodwill exceeds 25% of price; executed or committed medical director agreement; CPOM-compliant buyer entity
• Conventional acquisition: buyer 680+ FICO; 25–30% down; tangible-asset-heavy deal (equipment + leasehold > 60% of price); faster close for experienced aesthetics operators with strong personal financial statements
• New buyer (no aesthetics experience): SBA Microloan or SBA 7(a) small loans up to $350K; management experience in adjacent healthcare or personal-care services weighted favorably; physician or NP co-ownership often required for CPOM

Med-spa-specific acquisition underwriting concerns

Med spa acquisition underwriting involves several factors beyond standard business acquisition: (1) Medical director transition risk — the most common deal-killer in med spa acquisitions; if the seller's medical director will not stay through a transition period, the buyer must identify and contract with a replacement MD/NP/PA before lenders will fund; a gap in medical direction makes the practice temporarily non-operational under most state regulations. (2) Device age and obsolescence — a laser device with 5+ years of use and no manufacturer service agreement may have near-zero residual collateral value; buyers should negotiate price reductions for aging devices and factor in the cost of replacement into the total financing request. (3) State CPOM buyer-entity requirements — some states require a physician to hold at least 51% ownership for CPOM compliance; other states permit any licensed healthcare provider to own 100%; buyers must organize the acquisition entity under the applicable state framework before SBA eligibility review. (4) Non-compete covenants — the seller's non-compete agreement (typically 2–5 years, 10–25 miles) is a significant intangible asset protecting patient base retention; a poorly structured non-compete can result in patient attrition post-close that destroys the DSCR model. (5) DEA registration continuity — if the practice dispenses regulated substances, the buyer must obtain their own DEA registration before post-close operations; DEA registration transfer is not standard and takes 3–6 months to secure.